Dialysis Market Size, Share, Growth Analysis, By Type(Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD)), By Products and Services(Services, Equipment (Dialysis Machines, Water Treatment Systems, Others)), By End User(In-center Dialysis, Home Dialysis), By Region - Industry Forecast 2024-2031

Dialysis Market Driver

• In terms of cost and healthcare services, the overall burden of end-stage renal disease (ESRD) and chronic kidney disease (CKD) is one of the highest. One of the primary drivers of market expansion is the increasing prevalence of chronic kidney disease and renal failure. ESRD occurs when one or both kidneys cease to function correctly and the patient requires long-term renal infusion therapy or a kidney transplant. Thus, the rising frequency of ESRD is increasing the global financial burden of kidney disorders and is one of the primary drivers driving the increased revenue generation from services. According to the CDC, around 15% of the US population and 14% of Hispanics have CKD.
• The frequency of CKD has risen dramatically, fueling demand for efficient renal services with shorter wait times. The growing availability of highly qualified nephrologists in affluent countries has boosted the number of renal care institutions. Furthermore, to meet the increased need for renal care in emerging economies, investors are concentrating their efforts on expanding renal treatment centers in nations such as India, China, and Mexico. This is projected to propel market revenue generation in the following years. The availability of low-cost care in these countries is increasing the frequency of visitors to these clinics.

Dialysis Market Restraint

• Kidney transplantation is one of the alternative therapy choices for people with ESRD and stage III CKD, in which the patients receive a kidney from a donor and a healthy kidney replaces the damaged kidney. Better treatment outcomes associated with kidney transplant and the affordability of the surgery as a result of favorable reimbursement policies are expected to influence market growth over the forecast period. Patients with ESRD prefer kidney transplantation versus renal infusion because to the long-term benefits of the treatment. In addition, published studies and journals have indicated a rise in the cost of renal therapy as a result of the coronavirus epidemic in India. This could have a detrimental impact on market growth.